Results 91 to 100 of about 919 (164)

Optimal management of idiopathic macular holes

open access: yesClinical Ophthalmology, 2016
Haifa A Madi,1,* Ibrahim Masri,1,* David H Steel1,2 1Sunderland Eye Infirmary, Sunderland, 2Institute of Genetic Medicine, Newcastle University, International Centre for Life, Newcastle, UK *These authors contributed equally to this work Abstract ...
Madi HA, Masri I, Steel DH
doaj  

Efficacy of Intravitreal Ocriplasmin for Treatment of Vitreomacular Adhesion

open access: yes, 2015
PURPOSE: To evaluate the efficacy of a single intravitreal injection of ocriplasmin 125 μg across relevant subpopulations of patients with symptomatic vitreomacular adhesion (VMA)/vitreomacular traction (VMT), including when associated with macular hole.
Gandorfer, Arnd   +8 more
core   +1 more source

Baseline Predictors of Vitreomacular Adhesion/Traction Resolution Following an Intravitreal Injection of Ocriplasmin

open access: yes, 2016
BACKGROUND AND OBJECTIVE: To determine factors predicting response to ocriplasmin (Jetrea; ThromboGenics, Iselin, NJ) response in patients with symptomatic vitreomacular adhesion (VMA).PATIENTS AND METHODS: Combined analysis of two multicenter ...
Girach, Aniz   +8 more
core   +1 more source

Outcomes of different surgical procedures for optic disc pit: a meta-analysis

open access: yesJournal of the Egyptian Ophthalmological Society
Objective To assess the surgical outcomes of pars plana vitrectomy (PPV) in conjunction with various adjuvant procedures for optic disc pit maculopathy (ODPM).
Hussain A. Khaqan   +7 more
doaj   +1 more source

Clinical Ophthalmology Dovepress retinal breaks due to intravitreal ocriplasmin

open access: yes, 2020
: Ocriplasmin represents a new treatment option for numerous vitreoretinopathies involving an abnormal vitreomacular interface. While the drug may circumvent the traditional risks of surgical treatment, pharmacologic vitreolysis is not devoid of risk ...
Theodore Leng, Darius M Moshfeghi
core  

Editorial: Women in Science - Ophthalmology 2021. [PDF]

open access: yesFront Med (Lausanne), 2022
Thounaojam MC.
europepmc   +1 more source

OCRIPLASMIN FOR VITREOMACULAR TRACTION IN CLINICAL PRACTICE: The INJECT Study. [PDF]

open access: yesRetina, 2021
Steel DHW   +9 more
europepmc   +1 more source

Autologous <i>in vitreo</i> generated plasmin assisted vitrectomy in the pediatric population. [PDF]

open access: yesWorld J Clin Pediatr
Subramaniam P   +5 more
europepmc   +1 more source

Intravitreal injection associated rhegmatogenous retinal detachment: outcomes of a European analysis. [PDF]

open access: yesGraefes Arch Clin Exp Ophthalmol, 2021
Vounotrypidis E   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy